Pulmonx Reports Officer Changes & Compensation on Feb 21
Ticker: LUNG · Form: 8-K · Filed: Feb 21, 2024 · CIK: 1127537
| Field | Detail |
|---|---|
| Company | Pulmonx Corp (LUNG) |
| Form Type | 8-K |
| Filed Date | Feb 21, 2024 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.001, $580,000, $2,500,000, $2,500,000 b |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, compensatory-arrangements, corporate-governance
TL;DR
**Pulmonx just filed an 8-K about executive changes and compensation, so keep an eye on leadership shifts!**
AI Summary
Pulmonx Corporation filed an 8-K on February 21, 2024, reporting on the departure or election of directors or certain officers and their compensatory arrangements, as well as other events and financial statements. The filing indicates a change in leadership or compensation structure within the company, which is headquartered at 700 Chesapeake Drive, Redwood City, CA.
Why It Matters
Changes in executive leadership or compensation can signal shifts in company strategy, performance, or governance, impacting investor confidence and future direction.
Risk Assessment
Risk Level: medium — Changes in officers or their compensation can introduce uncertainty regarding future company direction and stability.
Key Players & Entities
- Pulmonx Corporation (company) — Registrant
- February 21, 2024 (date) — Date of earliest event reported
- Delaware (company) — State of Incorporation
- 700 Chesapeake Drive, Redwood City, CA 94063 (company) — Principal Executive Offices
- 001-39562 (company) — Commission File Number
FAQ
What was the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing was February 21, 2024.
What items were reported in this 8-K filing by Pulmonx Corporation?
The 8-K filing reported on 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers', 'Other Events', and 'Financial Statements and Exhibits'.
What is the business address of Pulmonx Corporation?
The business address of Pulmonx Corporation is 700 Chesapeake Drive, Redwood City, CA 94063.
What is the Commission File Number for Pulmonx Corporation?
The Commission File Number for Pulmonx Corporation is 001-39562.
In which state is Pulmonx Corporation incorporated?
Pulmonx Corporation is incorporated in Delaware.
Filing Stats: 1,686 words · 7 min read · ~6 pages · Grade level 11 · Accepted 2024-02-21 16:05:48
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value LUNG The Nasdaq Stock Market
- $580,000 — e will be paid an annual base salary of $580,000 and will be eligible to receive an annu
- $2,500,000 — for shares of common stock with a value $2,500,000 to be determined using a Black-Scholes
- $2,500,000 b — he "RSU"), to be determined by dividing $2,500,000 by the trailing 60-day average closing pr
Filing Documents
- lung-20240221.htm (8-K) — 42KB
- lettertogfrenchresignation.htm (EX-10.1) — 6KB
- employmentoffer-pulmonxxsw.htm (EX-10.2) — 32KB
- lungceotransitionprdraftv9.htm (EX-99.1) — 10KB
- image_0.jpg (GRAPHIC) — 8KB
- image_0b.jpg (GRAPHIC) — 9KB
- image_1a.jpg (GRAPHIC) — 387KB
- 0001127537-24-000012.txt ( ) — 751KB
- lung-20240221.xsd (EX-101.SCH) — 2KB
- lung-20240221_lab.xml (EX-101.LAB) — 23KB
- lung-20240221_pre.xml (EX-101.PRE) — 12KB
- lung-20240221_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On February 21, 2024, the Company issued a press release announcing the matters described in Item 5.02 above. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Letter Agreement, dated February 20, 2024 by and between Glendon E. French and Pulmonx Corporation 10.2 Offer Letter, dated February 19, 2024 by and between Steven S. Williamson and Pulmonx Corporation 99.1 Press Release of Pulmonx Corporation, dated February 21, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Pulmonx Corporation Dated: February 21, 2024 By: /S/ DAVID LEHMAN David Lehman General Counsel